RecallDepth
Class II Ongoing

Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-139-10

This recall is currently active, issued May 31, 2023. It was issued by Sagent Pharmaceuticals Inc.

Company
Sagent Pharmaceuticals Inc
Recall Initiated
May 19, 2023
Posted
May 31, 2023
Recall Number
D-0762-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,249,980 vials
Firm Location
Schaumburg, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide USA

Lot / Code Info

Lot: NFG101, EXP: 1/31/2024; Lot: NFG102, EXP: 9/30/2024; Lot: NFG201, 5/31/2025

More recalls by Sagent Pharmaceuticals Inc

View all recalls by this company →

Other recent Class II Drug recalls